Loxo Oncology (LOXO) News Today

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis

Source

Source	Headline
	Global CLL Therapeutics Market Set to Reach $9.2 Billion by 2032 finance.yahoo.com - March 25 at 1:28 PM
	MOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer finance.yahoo.com - March 11 at 10:35 AM
	David M Mott's Net Worth benzinga.com - February 26 at 12:29 AM
	Foghorn gets $300M plus investment from Lilly under cancer drug partnership bizjournals.com - February 8 at 8:06 PM
	Eli Lilly’s Jaypirca to lead BTK inhibitor market for leukemia msn.com - January 18 at 2:39 PM
	Iron Condor Alert: LLY Stock Could Net 40% In 4 Weeks msn.com - January 10 at 9:08 AM
	insitro Hires Chief Medical Officer to Advance Therapeutic Programs Toward the Clinic finance.yahoo.com - January 8 at 12:52 PM
	Foghorn Therapeutics Highlights Clinical Program Updates and Research Progress and Provides Strategic Objectives for 2024 markets.businessinsider.com - January 8 at 7:52 AM
	Eli Lilly surprised as POINT Biopharma acquisition remains incomplete msn.com - December 5 at 5:36 PM
	Lilly cancer drug cleared by FDA for expanded leukemia, lymphoma use finance.yahoo.com - December 4 at 2:57 PM
	Eli Lilly and Company (NYSE:LLY) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 4 at 2:02 PM
	Foghorn Therapeutics, Inc.: Foghorn Therapeutics Provides Third Quarter 2023 Financial and Corporate Update finanznachrichten.de - November 2 at 12:34 PM
	Citi continue to see upside to Eli Lilly & Co.'s 'already rich' valuation ca.investing.com - November 2 at 12:34 PM
	Foghorn Therapeutics Provides Third Quarter 2023 Financial and Corporate Update finance.yahoo.com - November 2 at 7:32 AM
	Lilly agrees to buy POINT Biopharma for $1.4bn msn.com - October 4 at 7:08 PM
	Eli Lilly to pay $1.4-billion for cancer-drug maker Point Biopharma msn.com - October 4 at 12:08 AM
	Point Biopharma stock soars on $1.4B takeover bid from Eli Lilly thestreet.com - October 3 at 7:07 PM
	POINT Biopharma (NASDAQ: PNT) Soars After Eli Lilly’s $1.4 Billion Acquisition msn.com - October 3 at 2:07 PM
	Eli Lilly to Pay $1.4 Billion for Cancer-Drug Maker Point Biopharma msn.com - October 3 at 2:07 PM
	Eli Lilly Acquiring Cancer Therapy Developer For $1.4 Billion—A Nearly 90% Premium msn.com - October 3 at 2:07 PM
	Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders finanznachrichten.de - September 26 at 10:16 AM
	Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders finance.yahoo.com - August 28 at 2:59 AM
	Propulsion of Medullary Thyroid Cancer Clinical Trial Pipeline as Novel and Extensive 15+ Therapies Likely to Enter in the Domain \| DelveInsight benzinga.com - August 25 at 10:23 PM
	Next-generation study launched via LSUHS partnership to aid rural cancer patients msn.com - August 16 at 6:58 PM
	Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla Platform finanznachrichten.de - August 10 at 11:15 AM
	Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ Platform finance.yahoo.com - August 10 at 11:15 AM
	Q2 2023 Eli Lilly and Co Earnings Call finance.yahoo.com - August 9 at 2:45 AM
	Merus Announces Financial Results for the Second Quarter 2023 and Provides Business Update benzinga.com - August 8 at 11:11 AM
	Circle Pharma strengthens its executive leadership team with two senior appointments in Clinical Development venturebeat.com - July 26 at 4:24 PM
	Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth benzinga.com - May 16 at 10:41 PM
	Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting markets.businessinsider.com - May 11 at 10:33 AM
	8-K: Foghorn Therapeutics Inc. marketwatch.com - May 8 at 10:02 PM
	Eli Lilly (LLY) Q1 2023 Earnings Call Transcript msn.com - April 28 at 4:30 PM
	Q1 2023 Eli Lilly and Co Earnings Call finance.yahoo.com - April 28 at 9:39 AM
	Bruton's Tyrosine Kinase (BTK) Inhibitors Market Report Provide in Depth Analysis of Key Drivers 2023-2030 marketwatch.com - April 12 at 3:54 PM
	The Pemetrexed Drug market analysis report examines the industry's growth trajectory from 2023 to 2030, with a CAGR valuation of 7.6%. marketwatch.com - April 10 at 3:36 PM
	Loxo Announces Groundbreaking Free ATS/CRM Offer Alongside Several Revolutionary Updates benzinga.com - March 18 at 10:00 PM
	U.S. FDA Broadens Indication for Verzenio® (abemaciclib) in HR+, HER2-, Node-Positive, High Risk Early Breast Cancer finance.yahoo.com - March 3 at 5:10 PM
	American Oncology Network Appoints Chairman and Vice Chairman of the Board of Managers finance.yahoo.com - February 22 at 9:14 PM
	Loxo Oncology Aims for Genetic Mutation Cancer Drug Approval in 2018 thestreet.com - February 17 at 8:03 AM
	NT Growth Factor Receptor Market 2023: Segment-Wise Market Analysis and Growth Potential 2028 marketwatch.com - February 16 at 10:02 PM
	3 Smart Stocks to Buy for a Potential Recession in 2023 entrepreneur.com - February 3 at 11:19 AM
	American Oncology Network Appoints New Board of Managers Members, Announces Resignation of Two Members benzinga.com - January 26 at 9:11 AM
	Medullary Thyroid Cancer Treatment Market Constantly Grow, Size, Share, Impressive Industry Growth, Analysis Report 2028 marketwatch.com - January 23 at 6:16 PM
	Here are 5 winners and 4 losers from the healthcare industry's most important event of the year businessinsider.com - January 13 at 8:44 PM
	Merus N.V.: CORRECTING and REPLACING --Merus Provides 2023 Outlook finanznachrichten.de - January 9 at 9:32 AM
	Merus N.V.: Merus Provides 2023 Outlook finanznachrichten.de - January 8 at 6:05 PM
	Merus Provides 2023 Outlook nz.finance.yahoo.com - January 8 at 1:04 PM
	Swiss start-up LOXO presents market-ready autonomous vehicle for last mile delivery finance.yahoo.com - January 5 at 1:43 PM
	Loxo@Lilly Presents Updated Pirtobrutinib Data from the Phase 1/2 BRUIN Clinical Trial at the 2022 American Society of Hematology Annual Meeting benzinga.com - December 12 at 10:05 PM

Get Loxo Oncology News Delivered to You Automatically

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

LOXO Media Mentions By Week

LOXO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LOXO
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

LOXO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LOXO Articles
This Week
▼
0

0
▲
LOXO Articles
Average Week

Get Loxo Oncology News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:LOXO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Loxo Oncology (LOXO) News Today

LOXO Media Mentions By Week

LOXO Media Sentiment

LOXO News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info